The Effect of Whole-Body Vibration Treatment Before Total Knee Arthroplasty

NCT05967637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2025-07-11

No results posted yet for this study

Summary

The study's objective is to investigate the effects of whole-body vibration therapy administered before surgery on various factors related to patients who undergo total knee arthroplasty. These factors include pain, swelling, skin temperature, normal joint movement, knee joint position sense, knee extensor muscle strength, functional status, and patient satisfaction.

Conditions

  • Whole-body Vibration
  • Arthropathy of Knee
  • Swelling/ Edema

Interventions

OTHER

Whole body vibration

The vibration will be applied for 10 minutes (30 seconds rest, 30 seconds training, 10 reps) in total with a low frequency (20 HZ) and low amplitude (2mm). Participants will be asked to stand in a squatting position by semi-flexing (30°) their knees during the 30-second vibration period.

OTHER

Sham-Whole body vibration

The sham-whole body vibration treatment will follow the same procedures with the vibration machine off.

Sponsors & Collaborators

  • Gulhane Training and Research Hospital

    collaborator OTHER_GOV
  • Gazi University

    lead OTHER

Principal Investigators

  • Zeynep Hazar · Gazi University

  • Cemil Yıldız · Gulhane Training and Research Hospital

  • Sevim Beyza Ölmez · Gazi University

  • Beyza Yazgan · Gazi University

  • İnci Ayaş · Gazi University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-08-01
Completion
2024-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05967637 on ClinicalTrials.gov